McBride Guzman (spademirror26)

Correlation analysis and network analysis showed that antibiotic enrichment and the bacterial community contributed significantly to the abundance of antibiotic-resistant genes (ARGs), further revealing the co-occurrence of int1, ARGs, and the potential bacterial hosts.Diazinon is one of the insecticides that represent a high risk for Costa Rican estuarine environments due to its widespread use in pineapple plantations. In estuaries, organisms are frequently submitted to stress caused by natural factors (e.g., continuous changes in salinity levels) and, additionally, to stress due to contamination. Therefore, the driving question of this study was will organisms be more susceptible to suffer the deleterious effects caused by diazinon because of the stress resulting from the salinity changes? The estuarine shrimp Penaeus vannamei was used as the model organism and two responses were measured osmoregulation (the physiological effect after a forced and continuous 24 h-exposure) and avoidance [the behavioural effect after a short (3 h) non-forced, multi-compartmented exposure]. Juveniles were exposed to diazinon (0.1, 1, 10 and 100 μg/L) at three different salinities (10, 20 and 30). Disruption in the capacity to regulate the haemolymph osmotic pressure was observed at a salinity of 30 in individuals exposed to diazinon and methanol (used as vehicle). At that salinity, the ability of shrimps to detect and avoid the highest diazinon concentrations was impaired. P. vannamei juveniles inhabit environments with a high variation in salinity, but with an optimum osmotic point close to a salinity of 20; therefore, the higher the salinity, the greater the vulnerability of shrimps to the effects of diazinon. From an ecological point of view, this combined effect of salinity and contamination might also limit the spatial distribution of the organisms. Anti Programmed Death-ligand (PD1/PD-L1) directed immune-checkpoint-inhibitors (ICI) are widely used to treat patients with advanced non-small cell lung cancer (NSCLC) who progress after first line chemotherapy. The best strategy after early progression under first line has not been specifically studied. We conducted a multicenter, retrospective study including all consecutive NSCLC patients progressing within the first 3months following introduction of first-line chemotherapy and being treated with second line ICI monotherapy or chemotherapy between March 2010 and November 2017. We analysed the clinicopathological data and outcome under second line chemotherapy vs. second line ICI objective response rate (ORR), progression-free survival (PFS), overall survival (OS. We identified 176 patients with refractory disease, 99 who received subsequent immunotherapy and 77 undergoing chemotherapy. The 2 populations were comparable regarding the main prognostic criteria, median age was 60, main histology was adenocarcimoma (68.2%). PFS was not significantly different between both treatments 1.9 [1.8-2.1] versus 1.6 month [1.4-2.0] (P=0.125). Compared to chemotherapy, ICI treated patients had a superior OS (P=0.03) (Median [95% CI] OS 4.6 [2.8-6.7] versus 4.2 months [3.4-5.9] and a non-significant improvement in ORR (17.2% versus 7.9%, respectively, P=0.072). Poor performance status (ECOG PS≥2) and a higher number of metastatic sites (≥3) were associated with poorer prognosis. KRAS-mutated patients did not seem to benefit more from ICI than chemotherapy. ICI appears to be the preferred second-line treatment for patients who are refractory to first line chemotherapy. ICI appears to be the preferred second-line treatment for patients who are refractory to first line chemotherapy.The aim of the present study was to evaluate histological and stereological changes, as well as the variations in the number and size of cells from diverse cell subpopulations in testes of newly hatched chicks treated with follicle stimulating hormone (FSH) and luteinizing hormone (L